Article / 18 December 2017 at 12:00 GMT

UPDATE: Why we're still keen on our corporate bond picks — #SaxoStrats

Fixed income Specialist / Saxo Bank

Recap trade ideas Vallourec 2.25% September 2024

The price of the bond rose marginally. The company is still running at full capacity in the US and improving oil prices may lead to new projects in the Middle East, which is a more lucrative market than the US. Although the company may run with a negative operating profit margin for another year, it has no repayments until 2019 and it has 2bn euros of undrawn revolver credit facility. The company has recently received a bid for its “drilling products” business for a cash amount of US$63m.

Afrexi 4.125% June 2024

The African supranational bank is rated much lower than its peers due to the fact that it is active in high-risk region. Afreximbank has extended a 1.5bn USD dollar facility in Zimbabwe and it is planning to lend $500m to Egyptian banks in 2018. African countries have been successfully borrowing through the international markets in the past few months, taking advantage of low interest rates.

Altice 7.25% May 2022 

Altice has been a rollercoaster. After Q3 results revealed higher leverage, the founder of the company has come back in an attempt to reorganise the company and work on capital structure. The first big debt repayment is in 2022, which gives space to the company to tackle its capital structure and operational issues. Altice has announced the sale of its Swiss business and it’s considering also selling the French Towers and Dominican Republic interests in an attempt to deleverage the business. At the same time, the company is looking to develop French fibre-optics and Altice USA Charter Communications and Comcast Cable have reached a preliminary pact to form a new interconnet in the New York market.

Tencent 3.375% May 2019

The stock was sold off at the end of November and then recovered last week. From a credit point of view, the company is still sound, net debt negative and growing, thanks to its dominance of China’s online social network. Although China is experiencing a slowdown, the company is in a good position to expand its product offering and monetise through various online products.

Valeant 4.5% May 2023

Valeant Pharmaceutical has worked hard in order to stabilise its core operations and has been able to issue 8NC4 with a 9% coupon and 2020 maturity in order to refinance near-term debt maturities. Valeant has the biggest contact lenses business in the world that is growing quickly in China and this may have a positive impact on the company’s cash flow. Valeant remains highly leveraged and price appreciation will depend on the capability of the company to deleverage its balance sheet.

Daniel CN Daniel CN
why not include Chinese government bonds? I love them. Even more so since Saxos ideas about a possible appreciation of the yuan. LGT, ICBC or others offer 3,6+% on the 1 year deposit Yuan account. With better risk ratio than Tencent.


The Saxo Bank Group entities each provide execution-only service and access to permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on or as a result of the use of the Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. When trading through your contracting Saxo Bank Group entity will be the counterparty to any trading entered into by you. does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of ourtrading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws. Please read our disclaimers:
- Notification on Non-Independent Invetment Research
- Full disclaimer

Check your inbox for a mail from us to fully activate your profile. No mail? Have us re-send your verification mail